전기수술 기기 시장 규모, 점유율, 동향 분석 보고서 : 방법별, 제품별, 지역별, 부문별 예측(2026-2033년)

Electrosurgical Devices Market Size, Share & Trends Analysis Report, By Method (Monopolar, Bipolar), By Product (Electrosurgical Generators, Active Electrodes, Dispersive Electrodes), By Region, And Segment Forecasts, 2026 - 2033

US $ 5,950 ￦ 8,957,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,462,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 13,473,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

전기수술 기기 시장 요약

세계의 전기수술 기기 시장 규모는 2025년에 72억 달러로 추정되며, 2033년까지 92억 5,000만 달러에 달할 것으로 예측됩니다.

2026년부터 2033년까지 CAGR 3.1%로 성장할 것으로 예상됩니다. 고령화에 따른 수술 건수 증가 및 만성질환 유병률 증가, 첨단 에너지 기기에 의존하는 최소침습 및 외래 수술의 보급 확대, 임상적 유효성과 안전성을 높이는 지속적인 기술 혁신(개량형 발전기기, 혈관 밀봉 시스템, 양극성/단극성 하이브리드, 통합 안전 기능 등) 등)을 들 수 있습니다.

기타 성장 요인으로는 신흥시장의 의료비 지출 및 병원 수용력 확대, 수술 중 출혈량 및 수술 시간 단축에 대한 집중(에너지 기반 지혈법 선호), 첨단 수술 기술에 대한 상환제도 강화 등을 들 수 있습니다.

시장 성장은 만성질환의 증가와 인구 고령화에 의해 촉진되고 있습니다. 예를 들어, 영국 심장재단(BHF)의 2024년 5월 발표에 따르면, 2024년 3월 말 기준 영국 내 심장 치료 대기자는 41만 4,596명으로 전월 대비 6,048명 증가했다고 합니다. 세계보건기구(WHO)의 추산에 따르면, 장애를 유발할 수 있는 치명적이지 않은 부상을 경험하는 세계 인구는 2,000만에서 5,000만 명에 달합니다. 이러한 사고와 부상의 증가에 따라 수술 기기에 대한 수요 확대가 예상됩니다.

고령화는 전기 수술 기기 산업의 주요 촉진요인입니다. 노인은 심혈관질환, 암, 관절 관련 질환 등 외과적 개입이 필요한 만성질환이나 상태에 걸리기 쉽기 때문입니다. 전 세계 노인 인구가 증가함에 따라 선택적 수술 및 응급 수술 건수도 비례하여 증가하여 신뢰할 수 있고 효율적인 전기 수술 기기에 대한 수요가 증가하고 있습니다. 병원과 수술 센터에서는 늘어나는 환자군의 수술 효율성 향상, 출혈량 감소, 합병증 최소화를 위해 첨단 전기 수술용 발전기 및 에너지 기기에 대한 투자를 진행하고 있습니다. 이러한 인구통계학적 추세는 특히 일본, 유럽, 북미 등 고령화가 급속히 진행되고 있는 지역에서 전기 수술 기술의 지속적이고 확대되는 시장을 보장합니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 전기외과 기기 시장 변수, 동향 및 범위

제4장 전기수술 기기 시장 : 방법별 추정·동향 분석

제5장 전기수술 기기 시장 : 제품별 추정·동향 분석

제6장 전기수술 기기 시장 : 지역별 추정·동향 분석(방법·제품별)

제7장 경쟁 구도

KSM

영문 목차

영문목차

Electrosurgical Devices Market Summary

The global electrosurgical devices market size was estimated at USD 7.20 billion in 2025 and is projected to reach USD 9.25 billion by 2033, growing at a CAGR of 3.1% from 2026 to 2033. Factors such as the rising surgical volumes from an ageing population and increasing prevalence of chronic diseases, growing adoption of minimally invasive and ambulatory surgical procedures that rely on advanced energy devices, and continuous technological innovation (improved generators, vessel-sealing systems, bipolar/monopolar hybrids and integrated safety features) that boost clinical efficacy and safety.

Additional drivers include expanding healthcare spending and hospital capacity in emerging markets, a greater focus on reducing intraoperative blood loss and procedure time (which favors energy-based hemostasis), and stronger reimbursement for advanced surgical techniques.

Market growth is being fueled by the increase in chronic diseases and the aging population. For instance, according to the British Heart Foundation (BHF) May 2024, the number of people on heart care waiting lists in England increased to 414,596 by the end of March 2024, a rise of 6,048 from the month before. The number of people experiencing non-fatal injuries globally, potentially resulting in disability, is estimated to be between 20 and 50 million by the WHO. As a result of this growing incident of accidents and injuries, there is expected to be an increase in the need for surgical devices.

The aging population is a major driver of the electrosurgical device industry because older individuals are more prone to chronic diseases and conditions that require surgical intervention, such as cardiovascular disorders, cancer, and joint-related issues. As the global geriatric population increases, the number of elective and emergency surgeries rises correspondingly, creating higher demand for reliable, efficient electrosurgical devices. Hospitals and surgical centers are investing in advanced electrosurgical generators and energy devices to improve operative efficiency, reduce blood loss, and minimize complications in this growing patient segment. This demographic trend ensures a sustained and expanding market for electrosurgical technology, especially in regions with rapidly aging populations like Japan, Europe, and North America.

Global Electrosurgical Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global electrosurgical devices market report based on the method, product and region:

• Method Outlook (Revenue, USD Million, 2021 - 2033)
• Monopolar
• Bipolar
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Electrosurgical Generators
• Active Electrodes
• Dispersive Electrodes
• Other Accessories
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Method
  • 1.1.2. Product
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Electrosurgical Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing healthcare infrastructure and surgical facilities
    • 3.2.1.2. Increasing prevalence of chronic diseases
    • 3.2.1.3. Increasing number of surgeries and minimally invasive procedures
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of electrosurgical systems
    • 3.2.2.2. Stringent regulatory requirements
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenge analysis
• 3.3. Electrosurgical Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Electrosurgical Devices Market: Method Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Electrosurgical Devices Market Method Movement Analysis
• 4.3. Global Electrosurgical Devices Market Size & Trend Analysis, by Method, 2021 to 2033 (USD Million)
• 4.4. Monopolar
  • 4.4.1. Monopolar market estimates and forecasts for 2021 to 2033, (USD Million)
• 4.5. Bipolar
  • 4.5.1. Bipolar market estimates and forecasts for 2021 to 2033, (USD Million)

Chapter 5. Electrosurgical Devices: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Electrosurgical Devices Market Product Movement Analysis
• 5.3. Global Electrosurgical Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 5.4. Electrosurgical Generators
  • 5.4.1. Electrosurgical generators market estimates and forecasts for 2021 to 2033, (USD Million)
• 5.5. Active Electrodes
  • 5.5.1. Active electrodes market estimates and forecasts for 2021 to 2033, (USD Million)
• 5.6. Dispersive Electrodes
  • 5.6.1. Dispersive electrodes market estimates and forecasts for 2021 to 2033, (USD Million)
• 5.7. Other Accessories
  • 5.7.1. Other accessories market estimates and forecasts for 2021 to 2033, (USD Million)

Chapter 6. Electrosurgical Devices Market: Regional Estimates & Trend Analysis by Method, Product

• 6.1. Regional Dashboard
• 6.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 6.3. North America
  • 6.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Competitive scenario
    • 6.3.2.3. Regulatory framework
    • 6.3.2.4. Reimbursement scenario
    • 6.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
  • 6.3.3. Canada
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Competitive scenario
    • 6.3.3.3. Regulatory framework
    • 6.3.3.4. Reimbursement scenario
    • 6.3.3.5. Canada market estimates and forecasts, 2021 - 2033
  • 6.3.4. Mexico
    • 6.3.4.1. Key country dynamics
    • 6.3.4.2. Competitive scenario
    • 6.3.4.3. Regulatory framework
    • 6.3.4.4. Reimbursement scenario
    • 6.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
• 6.4. Europe
  • 6.4.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 6.4.2. UK
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Competitive scenario
    • 6.4.2.3. Regulatory framework
    • 6.4.2.4. Reimbursement scenario
    • 6.4.2.5. UK market estimates and forecasts, 2021 - 2033
  • 6.4.3. Germany
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Competitive scenario
    • 6.4.3.3. Regulatory framework
    • 6.4.3.4. Reimbursement scenario
    • 6.4.3.5. Germany market estimates and forecasts, 2021 - 2033
  • 6.4.4. France
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Competitive scenario
    • 6.4.4.3. Regulatory framework
    • 6.4.4.4. Reimbursement scenario
    • 6.4.4.5. France market estimates and forecasts, 2021 - 2033
  • 6.4.5. Italy
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Competitive scenario
    • 6.4.5.3. Regulatory framework
    • 6.4.5.4. Reimbursement scenario
    • 6.4.5.5. Italy market estimates and forecasts, 2021 - 2033
  • 6.4.6. Spain
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Competitive scenario
    • 6.4.6.3. Regulatory framework
    • 6.4.6.4. Reimbursement scenario
    • 6.4.6.5. Spain market estimates and forecasts, 2021 - 2033
  • 6.4.7. Denmark
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Competitive scenario
    • 6.4.7.3. Regulatory framework
    • 6.4.7.4. Reimbursement scenario
    • 6.4.7.5. Denmark market estimates and forecasts, 2021 - 2033
  • 6.4.8. Sweden
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Competitive scenario
    • 6.4.8.3. Regulatory framework
    • 6.4.8.4. Reimbursement scenario
    • 6.4.8.5. Sweden market estimates and forecasts, 2021 - 2033
  • 6.4.9. Norway
    • 6.4.9.1. Key country dynamics
    • 6.4.9.2. Competitive scenario
    • 6.4.9.3. Regulatory framework
    • 6.4.9.4. Reimbursement scenario
    • 6.4.9.5. Norway market estimates and forecasts, 2021 - 2033
• 6.5. Asia Pacific
  • 6.5.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 6.5.2. Japan
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Competitive scenario
    • 6.5.2.3. Regulatory framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. Japan market estimates and forecasts, 2021 - 2033
  • 6.5.3. India
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Competitive scenario
    • 6.5.3.3. Regulatory framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. India market estimates and forecasts, 2021 - 2033
  • 6.5.4. China
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Competitive scenario
    • 6.5.4.3. Regulatory framework
    • 6.5.4.4. Reimbursement scenario
    • 6.5.4.5. China market estimates and forecasts, 2021 - 2033
  • 6.5.5. South Korea
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Competitive scenario
    • 6.5.5.3. Regulatory framework
    • 6.5.5.4. Reimbursement scenario
    • 6.5.5.5. South Korea market estimates and forecasts, 2021 - 2033
  • 6.5.6. Australia
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Competitive scenario
    • 6.5.6.3. Regulatory framework
    • 6.5.6.4. Reimbursement scenario
    • 6.5.6.5. Australia market estimates and forecasts, 2021 - 2033
  • 6.5.7. Thailand
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Competitive scenario
    • 6.5.7.3. Regulatory framework
    • 6.5.7.4. Reimbursement scenario
    • 6.5.7.5. Thailand market estimates and forecasts, 2021 - 2033
• 6.6. Latin America
  • 6.6.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 6.6.2. Brazil
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Competitive scenario
    • 6.6.2.3. Regulatory framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. Brazil market estimates and forecasts, 2021 - 2033
  • 6.6.3. Argentina
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Competitive scenario
    • 6.6.3.3. Regulatory framework
    • 6.6.3.4. Reimbursement scenario
    • 6.6.3.5. Argentina market estimates and forecasts, 2021 - 2033
• 6.7. MEA
  • 6.7.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 6.7.2. South Africa
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Competitive scenario
    • 6.7.2.3. Regulatory framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. South Africa market estimates and forecasts, 2021 - 2033
  • 6.7.3. Saudi Arabia
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Competitive scenario
    • 6.7.3.3. Regulatory framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
  • 6.7.4. UAE
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Competitive scenario
    • 6.7.4.3. Regulatory framework
    • 6.7.4.4. Reimbursement scenario
    • 6.7.4.5. UAE market estimates and forecasts, 2021 - 2033
  • 6.7.5. Kuwait
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Competitive scenario
    • 6.7.5.3. Regulatory framework
    • 6.7.5.4. Reimbursement scenario
    • 6.7.5.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
  • 7.2.1. Innovators
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Global Key company market share analysis, 2025
  • 7.3.4. B. Braun Melsungen AG
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Boston Scientific Corporation
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Bovie Medical Corporation
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. BOWA-electronic GmbH & Co. KG
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. CONMED Corporation
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Erbe Elektromedizin GmbH
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Johnson & Johnson
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Medtronic Plc
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Olympus Corporation
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Smith & Nephew Plc.
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives
• 7.4. Heat Map Analysis/ Company Market Position Analysis
• 7.5. Estimated Company Market Share Analysis, 2025
• 7.6. List of Other Key Market Players

관련자료